An evaluation of biochemical aspects of intravenous fructose, sorbitol and xylitol administration in man.
D000136:Acid-Base Equilibrium; D000255:Adenosine Triphosphate / Q000378:metabolism; D001692:Biological Transport; D001786:Blood Glucose / Q000032:analysis; D004734:Energy Metabolism; D005632:Fructose / Q000378:metabolism* / Q000494:pharmacology; D005947:Glucose / Q000096:biosynthesis; D006003:Glycogen / Q000378:metabolism; D006801:Humans; D007263:Infusions, Parenteral; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007773:Lactates / Q000378:metabolism; D019344:Lactic Acid; D009243:NAD / Q000378:metabolism; D010766:Phosphorylation; D011773:Pyruvates / Q000378:metabolism; D019289:Pyruvic Acid; D013012:Sorbitol / Q000378:metabolism*; D014280:Triglycerides / Q000096:biosynthesis; D014993:Xylitol / Q000378:metabolism*
D001786:Blood Glucose; D007328:Insulin; D007773:Lactates; D011773:Pyruvates; D014280:Triglycerides; D009243:NAD; D005632:Fructose; D019344:Lactic Acid; D013012:Sorbitol; D019289:Pyruvic Acid; D000255:Adenosine Triphosphate; D006003:Glycogen; D005947:Glucose; D014993:Xylitol